Tuesday, May 8, 2018

Supernus Pharma Reports Q1 Earnings Per Share $0.49

SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE

* Q1 REVENUE $90.4 MILLION VERSUS I/B/E/S VIEW $85 MILLION

* Q1 EARNINGS PER SHARE VIEW $0.33 — THOMSON REUTERS I/B/E/S
* SUPERNUS – FOR 2018, REITERATES ITS PRIOR GUIDANCE FOR NET PRODUCT SALES, RESEARCH AND DEVELOPMENT EXPENSES
* SUPERNUS – FOR 2018, ALSO REITERATES ITS PRIOR GUIDANCE FOR OPERATING EARNINGS
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.